These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1309 related items for PubMed ID: 24907012

  • 1. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F, Hasan SK.
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [Abstract] [Full Text] [Related]

  • 2. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM, He LZ, Warrell RP, Wang ZG, Pandolfi PP.
    Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10173-8. PubMed ID: 10954752
    [Abstract] [Full Text] [Related]

  • 3. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.
    Haematologica; 2007 Mar 29; 92(3):323-31. PubMed ID: 17339181
    [Abstract] [Full Text] [Related]

  • 4. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
    Jing Y.
    Leuk Lymphoma; 2004 Apr 29; 45(4):639-48. PubMed ID: 15160934
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D, Solomon E.
    Curr Top Microbiol Immunol; 1997 Apr 29; 220():81-112. PubMed ID: 9103677
    [Abstract] [Full Text] [Related]

  • 6. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
    Grimwade D, Mistry AR, Solomon E, Guidez F.
    Cancer Treat Res; 2010 Apr 29; 145():219-35. PubMed ID: 20306254
    [Abstract] [Full Text] [Related]

  • 7. Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide.
    Nichol JN, Garnier N, Miller WH.
    Best Pract Res Clin Haematol; 2014 Mar 29; 27(1):19-31. PubMed ID: 24907014
    [Abstract] [Full Text] [Related]

  • 8. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C.
    Blood; 1996 Mar 01; 87(5):1939-50. PubMed ID: 8634442
    [Abstract] [Full Text] [Related]

  • 9. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
    Coltella N, Valsecchi R, Ponente M, Ponzoni M, Bernardi R.
    Clin Cancer Res; 2015 Aug 15; 21(16):3685-94. PubMed ID: 25931453
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z.
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun 29; 362(1482):959-71. PubMed ID: 17317642
    [Abstract] [Full Text] [Related]

  • 11. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D, Oniashvili N, Parnes D, Klein A, Muchtar E, Yeshaya J, Aviram A, Rabizadeh E, Raanani P.
    Cancer Genet; 2015 Nov 29; 208(11):575-9. PubMed ID: 26471811
    [Abstract] [Full Text] [Related]

  • 12. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov 29; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A, Cornic M, Gourmel B, Lefebvre P, Degos L, Chomienne C.
    Cell Mol Biol (Noisy-le-grand); 1994 May 29; 40(3):263-74. PubMed ID: 7920173
    [Abstract] [Full Text] [Related]

  • 14. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
    Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P.
    Blood; 1998 Sep 01; 92(5):1758-67. PubMed ID: 9716606
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of the antileukemia activities of retinoid and arsenic.
    Nitto T, Sawaki K.
    J Pharmacol Sci; 2014 Sep 01; 126(3):179-85. PubMed ID: 25319615
    [Abstract] [Full Text] [Related]

  • 16. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
    Puccetti E, Ruthardt M.
    Leukemia; 2004 Jul 01; 18(7):1169-75. PubMed ID: 15103387
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.
    Haematologica; 2005 Dec 01; 90(12):1607-16. PubMed ID: 16330433
    [Abstract] [Full Text] [Related]

  • 18. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A.
    Blood; 1998 Apr 15; 91(8):2634-42. PubMed ID: 9531570
    [Abstract] [Full Text] [Related]

  • 19. PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia.
    Ohnishi K.
    Int J Clin Oncol; 2007 Oct 15; 12(5):313-7. PubMed ID: 17929112
    [Abstract] [Full Text] [Related]

  • 20. [Pathogenesis of Acute Promyelocytic Leukemia].
    Matsushita H.
    Rinsho Byori; 2015 May 15; 63(5):631-42. PubMed ID: 26524903
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 66.